Translation Acceleration Grant

Translation Acceleration Grants


Prostate Cancer Canada (PCC) has invited applications for investigator-initiated Translation Acceleration Grants (TAG) that address a significant issue in the management of prostate cancer, with a high potential of preventing disease progression and/or improving quality of life in the short term.
 
Starting in 2014, each competition has addressed a significant issue in the management of prostate cancer. The intent of the program is not to support new discovery. Rather the grants should leverage existing knowledge and capabilities to accelerate impact without overlapping currently funded Prostate Cancer Canada and Movember foundation initiatives.

TAG1: Aggressive vs. indolent prostate cancer
TAG2: Novel therapeutics for aggressive disease
True Nth Survivorship Grants (TAG3)
TAG4: Innovative approaches to manage prostate cancer

These opportunities were awarded by Prostate Cancer Canada and proudly funded in part by the Movember Foundation.
smaller-still.jpg
See Funded Project Database for information on funded grants.




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Université de Sherbrooke Researchers’ Findings Published in Cancer Research

Sherbrooke, November 16, 2017 – Prostate cancer, the most common cancer in men, affects one out of seven Canadian men.
More

12 innovative Canadian prostate cancer researchers set out to make new Discoveries

Toronto, ON – September 28, 2017: 12 forward-thinking Canadian prostate cancer researchers have been rewarded for their innovation with Movember Discovery Grants.
More

Gray Tools '2017 Together We Are Stronger' campaign a success in creating awareness and raising funds for prostate cancer

BRAMPTON, Ontario, Sept 26, 2017 (GLOBE NEWSWIRE) -- Gray Tools Canada Inc, in cooperation with Prostate Cancer Canada, is proud to announce that its “2017 Together We Are Stronger” initiative raised $4,000, which will go directly towards funding valuable research that is needed to improve the way we diagnose, treat, and support men living with the disease.
More


Click here for news archive